Abstract
Rowachol, a proprietary mixture of the six monoterpenes menthol, menthone, borneol, cineole, camphene and pinene in olive oil, reduced the lithogenicity of bile (Doran et al. 1979) and caused dissolution of cholesterol gallstones in man (Bell and Doran 1979). Daily administration of the drug (6–9 capsules) to 16 patients for periods of 2–28 weeks gave a progressive increase in serum HDL-cholesterol concentration with no accompanying change in the concentrations of serum total cholesterol or triglyceride (Bell et al. 1980) (Fig. 1). Similar effects in humans have been shown recently by Leiss and von Bergmann (1985) who administered Rowachol (200 mg t.i.d) to young healthy volunteers and measured a significant increase in the ratio of HDL-cholesterol to total cholesterol in serum.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bell GD, Doran J (1979) Gallstone dissolution in man using an essential oil preparation. Brit Med J 1:24
Bell GD, Bradshaw JP, Burgess A, Ellis W, Hatton J, Middleton A, Middleton B, Orchard T, White DA (1980) Elevation of serum high density lipoprotein cholesterol by Rowachol, a proprietary mixture of six pure monoterpenes. Atherosclerosis 36:47–54
Bell GD, Clegg RJ, Ellis WR, Middleton B, White DA (1984) The effects of 3,5–5-trimethylcyclohexanol on hepatic cholesterol synthesis, bile-flow and biliary lipid secretion in the rat. Br J Pharmacol 81:183–187
Clegg RJ, Middleton B, Bell GD, White DA (1980) Inhibition of hepatic cholesterol synthesis and S-3-hydroxy-3-methylglutaryl-CoA reductase by mono-and bicyclic monoterpenes administered in vivo. Biochem Pharmacol 29:2125–2127
Clegg RJ, Middleton B, Bell GD, White DA (1982) The mechanism of cyclic monoterpene inhibition of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase in vivo in the rat. J Biol Chem 257:2294–2299
Doran J, Keighley MRB, Bell GD (1979) Rowachol — possible treatment for cholesterol gallstones. Gut 20:312–317
Leiss O, Bergmann K von (1985) Effect of Rowachol on biliary lipid secretion and serum lipids in normal volunteers. Gut 26:32–37
Middleton A, White DA, Bell GD, Middleton B (1983) In vivo inhibition of hepatic lipogenesis in the rat by cyclandelate (3,3′,5-trimethylcyclohexanylmandelate). Biochem Pharmacol 32:3079–3083
Middleton B, Middleton A, Miciak A, White DA, Bell GD (1983) The inhibition of hepatic S-3-hydroxy-3-methylglutaryl-CoA reductase by 3,3,5-trimethylcyclohexanol and its mandelicacid ester, cyclandelate. Biochem Pharmacol 32:649–651
Middleton B, Middleton A, White DA, Bell GD (1984) Cyclandelate decreases pre-established atherosclerosis in the rabbit. Atherosclerosis 51:171–178
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
White, D.A., Bell, G.D., Cacciaguerra, F., Middleton, B. (1987). The Influence of Terpenes and Analogues on Parameters of Atherosclerosis. In: Paoletti, R., Kritchevsky, D., Holmes, W.L. (eds) Drugs Affecting Lipid Metabolism. Proceedings in Life Sciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71702-4_41
Download citation
DOI: https://doi.org/10.1007/978-3-642-71702-4_41
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71704-8
Online ISBN: 978-3-642-71702-4
eBook Packages: Springer Book Archive